Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
5h
Hosted on MSNOzempic Shows Potential for Alcohol Addiction in TrialWeekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...
Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...
As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Once opened, compounded semaglutide typically lasts 28 days in the fridge. Compounded semaglutide, which contains the same active ...
Rybelsus (semaglutide) is a brand-name oral tablet prescribed for type 2 diabetes. As with other drugs, Rybelsus can cause side effects, such as nausea, vomiting, and constipation. Read on to ...
The USFDA’s approval makes the drug, chemically known as semaglutide ... in the kidney disease space as it has an alternate mechanism of action to current standard of care (SOC) in CKD, says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results